BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19558584)

  • 1. A comprehensive review of biomarkers in psoriasis.
    Rashmi R; Rao KS; Basavaraj KH
    Clin Exp Dermatol; 2009 Aug; 34(6):658-63. PubMed ID: 19558584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers.
    van Lingen RG; Poll MK; Seyger MM; de Jong EM; van de Kerkhof PC; van Erp PE
    Arch Dermatol Res; 2008 Nov; 300(10):561-7. PubMed ID: 18496701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature of cell kinetics in psoriatic epidermis.
    Doger FK; Dikicioglu E; Ergin F; Unal E; Sendur N; Uslu M
    J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis.
    Nagpal S; Thacher SM; Patel S; Friant S; Malhotra M; Shafer J; Krasinski G; Asano AT; Teng M; Duvic M; Chandraratna RA
    Cell Growth Differ; 1996 Dec; 7(12):1783-91. PubMed ID: 8959347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis: genetic associations and immune system changes.
    Liu Y; Krueger JG; Bowcock AM
    Genes Immun; 2007 Jan; 8(1):1-12. PubMed ID: 17093502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis mediated by cytolytic molecules might be responsible for maintenance of psoriatic plaques.
    Kastelan M; Massari LP; Brajac I
    Med Hypotheses; 2006; 67(2):336-7. PubMed ID: 16563649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesional psoriatic T cells contain the capacity to induce a T cell activation molecule CDw60 on normal keratinocytes.
    Skov L; Chan LS; Fox DA; Larsen JK; Voorhees JJ; Cooper KD; Baadsgaard O
    Am J Pathol; 1997 Feb; 150(2):675-83. PubMed ID: 9033280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes.
    Albanesi C; De Pità O; Girolomoni G
    Clin Dermatol; 2007; 25(6):581-8. PubMed ID: 18021896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble biomarkers in psoriasis.
    Enerbäck C
    Eur J Dermatol; 2011; 21(6):844-50. PubMed ID: 21856557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs: novel regulators in skin inflammation.
    Sonkoly E; Ståhle M; Pivarcsi A
    Clin Exp Dermatol; 2008 May; 33(3):312-5. PubMed ID: 18419608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of psoriasis.
    Kadunce DP; Krueger GG
    Dermatol Clin; 1995 Oct; 13(4):723-37. PubMed ID: 8785878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab monotherapy in psoriasis: a case of rapid clinical and histological response.
    Vincek V; Jacob SE; Nassiri M; Herbert LM; Nadji M; Kerdel FA
    Int J Dermatol; 2004 Apr; 43(4):303-8. PubMed ID: 15090021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different properties of three isoforms (alpha, beta, and gamma) of transcription factor AP-2 in the expression of human keratinocyte genes.
    Oyama N; Takahashi H; Tojo M; Iwatsuki K; Iizuka H; Nakamura K; Homma Y; Kaneko F
    Arch Dermatol Res; 2002 Aug; 294(6):273-80. PubMed ID: 12192491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration and functional analysis of IL-10 receptors in human epidermal cells: decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriatic glucocorticosteroid in normal cultured keratinocytes.
    Michel G; Mirmohammadsadegh A; Olasz E; Jarzebska-Deussen B; Müschen A; Kemény L; Abts HF; Ruzicka T
    J Immunol; 1997 Dec; 159(12):6291-7. PubMed ID: 9550434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of corticotropin-releasing hormone and receptor in the pathogenesis of psoriasis.
    Zhou C; Yu X; Cai D; Liu C; Li C
    Med Hypotheses; 2009 Oct; 73(4):513-5. PubMed ID: 19560286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A induces the unfolded protein response in keratinocytes.
    Hibino M; Sugiura K; Muro Y; Shimoyama Y; Tomita Y
    Arch Dermatol Res; 2011 Sep; 303(7):481-9. PubMed ID: 21221615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocytes as targets for interleukin-10-related cytokines: a putative role in the pathogenesis of psoriasis.
    Boniface K; Lecron JC; Bernard FX; Dagregorio G; Guillet G; Nau F; Morel F
    Eur Cytokine Netw; 2005 Dec; 16(4):309-19. PubMed ID: 16464746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible association of psoriasis and reduced bone mineral density due to increased TNF-alpha and IL-6 concentrations.
    Kastelan D; Kastelan M; Massari LP; Korsic M
    Med Hypotheses; 2006; 67(6):1403-5. PubMed ID: 16844318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin.
    Begon E; Michel L; Flageul B; Beaudoin I; Jean-Louis F; Bachelez H; Dubertret L; Musette P
    Eur J Dermatol; 2007; 17(6):497-506. PubMed ID: 17951129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between keratinocytes and immune cells--recent insights into psoriasis pathogenesis.
    Tonel G; Conrad C
    Int J Biochem Cell Biol; 2009 May; 41(5):963-8. PubMed ID: 19027868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.